The Complex Ethics of First in Human Stem Cell Clinical Trials

, , &
American Journal of Bioethics Neuroscience 3 (2):14-16 (2012)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1080/21507740.2012.675010

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 93,296

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Intracranial Stem Cell-Based Transplantation: Reconsidering the Ethics of Phase 1 Clinical Trials in Light of Irreversible Interventions in the Brain.Pascale Hess - 2012 - American Journal of Bioethics Neuroscience 3 (2):3-13.
Refining Ethical Guidelines for Early Clinical Trials of Pluripotent Stem-Cell-Derived Therapeutics for Parkinson's Disease.Audrey R. Chapman - 2015 - American Journal of Bioethics Neuroscience 6 (1):65-66.
Ethical Criteria for Human Trials of Stem-Cell-Derived Dopaminergic Neurons in Parkinson's Disease.Samia A. Hurst, Alex Mauron, Shahan Momjian & Pierre R. Burkhard - 2015 - American Journal of Bioethics Neuroscience 6 (1):52-60.
Improving Subject Safety in High-Risk Phase I Trials With Stem Cell-Based Candidate Therapies.Audrey R. Chapman - 2012 - American Journal of Bioethics Neuroscience 3 (2):18-20.
Resolving Ethical Issues in Stem Cell Clinical Trials: The Example of Parkinson Disease.Bernard Lo & Lindsay Parham - 2010 - Journal of Law, Medicine and Ethics 38 (2):257-266.
Uncertain translation, uncertain benefit and uncertain risk: Ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.Ronald K. F. Fung & Ian H. Kerridge - 2011 - Bioethics 27 (2):89-96.
Evaluating the First-in-Human Clinical Trial of a Human Embryonic Stem Cell-Based Therapy.Audrey R. Chapman & Courtney C. Scala - 2012 - Kennedy Institute of Ethics Journal 22 (3):243-261.
Efficacy Testing as a Primary Purpose of Phase 1 Clinical Trials: Is it Applicable to First-in-Human Bionics and Optogenetics Trials?Frederic Gilbert, Alexander R. Harris & Robert M. I. Kapsa - 2012 - American Journal of Bioethics Neuroscience 3 (2):20-22.
Safety Issues In Cell-Based Intervention Trials.Liza Dawson, Alison S. Bateman-House, Dawn Mueller Agnew, Hilary Bok, Dan W. Brock, Aravinda Chakravarti, Mark Greene, Patricia King, Stephen J. O'Brien, David H. Sachs, Kathryn E. Schill, Andrew Siegel & Davor Solter - 2003 - Fertility and Sterility 80 (5):1077-1085.
Allowing Innovative Stem Cell-Based Therapies Outside of Clinical Trials: Ethical and Policy Challenges.Insoo Hyun - 2010 - Journal of Law, Medicine and Ethics 38 (2):277-285.

Analytics

Added to PP
2018-06-22

Downloads
1 (#1,913,683)

6 months
5 (#710,311)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

The Ethical Dilemmas of Experimental Invasive Brain Technologies.Pascale Hess - 2014 - American Journal of Bioethics Neuroscience 5 (3):18-20.

Add more citations

References found in this work

Add more references